Samotus O, et al. - Experts attempted to analyze the neck motion and selection of relevant muscles and dosing with the intention of improving Botulinum toxin type A (BoNT-A) therapy for the treatment of cervical dystonia (CD). When compared to the visual determination, faster optimal muscle selections could be achieved via clinical judgement guided by kinematic analysis of CD biomechanics, which could also minimize the use of higher BoNT-A doses. This, in turn, would lead to comparable and potentially better treatment outcomes.